Patent Ductus Arteriosus. Patent ductus arteriosus
Conditions
Interventions
Intervention 1: Intervention group: Oral ibuprofen ten milligrams per kilogram of body weight per day, for three days. Intervention 2: Intervention group: Oral acetaminophen seven milligrams per kilog
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 28 Days
Inclusion criteria
Inclusion criteria: Infants less than 28 days old referring to Amir Kabir Hospital with Patent Ductus Arteriosus Parental consent for participation in the study No G6PD Enzymatic Deficiency
Exclusion criteria
Exclusion criteria: Dissatisfaction with using their information in the study Neonates with congenital heart defects that Patent Ductus Arteriosus were life giving, such as pulmonary artery atresia, congenital or chromosomal major abnormalities, the history of using non-steroidal anti-inflammatory drugs during pregnancy by mother, the presence of Hydrops Fetalis, and a continuous increase in Pulmonary Blood Pressure. Leaving the hospital with personal consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patent Ductus Arteriosus Closure Status. Timepoint: Before intervention for diagnosis and within three days interval of starting the drug. Method of measurement: Echocardiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactYazdan Ghandi
Arak University of Medical Sciences
Outcome results
None listed